Protocol Ledger

NCT07476729 · Phase III · RECRUITING

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

Interventional Phase III clinical trial protocol NCT07476729 sponsored by Charite University, Berlin, Germany in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-09-01 Enrollment: 750 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07476729
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)750 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07476729
Protocol FieldVerified Registry Value
NCT IdentifierNCT07476729
Consolidated Lead SponsorCharite University, Berlin, Germany
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment750 participants (ESTIMATED)
Registered Start Date2026-09-01
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07476729
Hospital Research SiteLocationSite Profile
Fakultni nemocnice v MotolePrague, CzechiaOpen Hospital Dossier ->
RigshospitaletCopenhagen, DenmarkOpen Hospital Dossier ->
Charité Universitätsmedizin BerlinBerlin, GermanyOpen Hospital Dossier ->
Oslo University HospitalOslo, NorwayOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI